LEQEMBI ® [ (lecanemab-irmb) 100 mg/mL injection for intravenous use] is indicated for the treatment of Alzheimer's disease (AD). Treatment with LEQEMBI should be initiated in patients with mild ...
A new study has revealed that people living with Attention Deficit Hyperactivity Disorder (ADHD) in the United Kingdom are not living as long as their peers.